Intellipharmaceutics International Inc. (IPCI)

[fabius]

You are correct, that's the usual approach when you want to start a negotiation.

But if we want to try to find the reasons for a counter-intuitive behaviour by Odidi - and we assume he is not out of his mind, then:

1 - he could already have (from a long time) a LOI which for example states that: get Rexista approved (or FDA accepted), secure your PRODRAS patent, partner half of your ANDA's and we'll value your company xxx (I'm just roughly guessing)

2 - the value given by the market to smallcap biotechs is more than often just a fraction of what big pharma then agrees to pay: market correctly discounts for any uncertainty , the same uncertainty that suddenly disappears when the contract/partnership/buyout comes into place; so ultimate real value is given by how much a big player is willing to pay

IF (very big IF) this scenario falls close to reality, then why bothering into PR, promotions, marketing and so on. Just run like hell towards the required accomplishments to get the deal done.
Think a company like Purdue, which is not listed (and therefore less bond to regulations in terms of communication) which agrees with Odidi as per above, requiring to be tight lipped.

otherwise we could have:

3 - he is completely incompetent (which I think is not)
4 - the company is a fraud veichle (which recent FDA approvals should prove is not)

Remember: JUST MY GUESSING, since I couldn't come out with a plausible explanation on why somebody should prefer to say nothing about his revolutionary gem, instead of going out and shout it loud.

GLTA